Mar 30, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 12, 2026 06:15PM
Dec 18, 2025 07:31AM
Dec 18, 2025 07:31AM
Nov 13, 2025 05:21PM Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
Nov 5, 2025 07:16AM
Nov 5, 2025 07:16AM
Oct 22, 2025 07:20AM
Oct 1, 2025 07:17AM
Oct 1, 2025 07:17AM
Sep 23, 2025 05:02PM
Sep 23, 2025 05:01PM Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Sep 9, 2025 07:20AM
Aug 14, 2025 05:05PM
Jun 25, 2025 06:04PM
May 20, 2025 10:17AM
Apr 28, 2025 07:41AM
Apr 14, 2025 08:15AM
Apr 14, 2025 08:15AM DELETED: Aditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis, and Stiff Person
Apr 2, 2025 08:17AM
Apr 2, 2025 08:15AM
Mar 24, 2025 08:15AM
Mar 18, 2025 07:22AM
Mar 17, 2025 08:15AM
Mar 6, 2025 08:15AM
Mar 6, 2025 08:15AM Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome
Feb 14, 2025 05:06PM
Nov 14, 2024 07:15AM
Nov 7, 2024 08:30AM
Nov 6, 2024 08:30AM
Oct 31, 2024 08:30AM
Oct 28, 2024 08:15AM
Oct 21, 2024 08:15AM Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern
Oct 17, 2024 07:15AM
Oct 10, 2024 08:15AM
Oct 10, 2024 07:13AM
Oct 8, 2024 08:15AM
Oct 3, 2024 08:15AM
Sep 24, 2024 08:15AM
Sep 20, 2024 08:15AM Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025
Sep 17, 2024 05:11PM
Sep 9, 2024 08:15AM
Aug 13, 2024 05:19PM
Jul 25, 2024 08:30AM
Jun 25, 2024 05:46PM
Apr 2, 2024 08:30AM
Mar 12, 2024 07:12AM Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks
Feb 13, 2024 05:49PM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All